Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages: Implications for the pathogenesis of Alzheimer's disease

Huangui Xiong, Laura McCabe, Joseph Costello, Eric Anderson, Gregory Weber, Tsuneya Ikezu

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Amyloid-β peptide (Aβ), the major component of amyloid plaques, can activate brain mononuclear phagocytes (MP; macrophages and microglia), leading to their secretion of neurotoxins. Recent studies strongly suggest that MP-mediated neurotoxicity plays an important role in the pathogenesis of Alzheimer's disease (AD). To further explore this notion, human monocyte-derived macrophages (MDM) were stimulated with naturally secreted α-processing soluble amyloid precursor protein/p3 (αAPPs/p3) or β-processing APP/Aβ (βAPPs/Aβ). MDM conditioned media (MCM) was recovered and tested for its ability to activate recombinant N-methyl-D-aspartate (NMDA) receptor subtype NR1a/NR2B expressed in Xenopus oocytes. Pressure ejection of αAPPs/p3- and βAPPs/Aβ-stimulated MCM produced inward currents of 59.5±8.9 nA (mean±S.E.M., n=31) and 111.1±21.0 nA (n=42) in NR1a/NR2B-expressing oocytes, respectively. The MCM-induced currents were concentration dependent and blocked by 50 μM of the NMDA receptor antagonist 2-amino-5-phosphnovalerate, but not by a non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (20 μM). The αAPPs/p3- and βAPPs/Aβ-stimulated MCM placed in non-injected oocytes failed to generate inward current. These results demonstrate that APPs/Aβ-stimulated MCM directly activate NMDA receptor subtypes relevant in the pathogenesis of AD.

Original languageEnglish (US)
Pages (from-to)905-911
Number of pages7
JournalNeurobiology of Aging
Volume25
Issue number7
DOIs
StatePublished - Aug 1 2004

Fingerprint

Conditioned Culture Medium
Alzheimer Disease
Macrophages
Amyloid beta-Protein Precursor
N-Methyl-D-Aspartate Receptors
Oocytes
6-Cyano-7-nitroquinoxaline-2,3-dione
D-Aspartic Acid
Aptitude
Amyloid Plaques
Neurotoxins
Microglia
Phagocytes
Xenopus
Amyloid
Pressure
Brain

Keywords

  • Alzheimer's disease
  • Amyloid precursor protein
  • Macrophages
  • NMDA receptors
  • PC12 cells
  • Xenopus oocytes

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages : Implications for the pathogenesis of Alzheimer's disease. / Xiong, Huangui; McCabe, Laura; Costello, Joseph; Anderson, Eric; Weber, Gregory; Ikezu, Tsuneya.

In: Neurobiology of Aging, Vol. 25, No. 7, 01.08.2004, p. 905-911.

Research output: Contribution to journalArticle

Xiong, Huangui ; McCabe, Laura ; Costello, Joseph ; Anderson, Eric ; Weber, Gregory ; Ikezu, Tsuneya. / Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages : Implications for the pathogenesis of Alzheimer's disease. In: Neurobiology of Aging. 2004 ; Vol. 25, No. 7. pp. 905-911.
@article{f2a2f2de215e4ec0acf23063c7851615,
title = "Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages: Implications for the pathogenesis of Alzheimer's disease",
abstract = "Amyloid-β peptide (Aβ), the major component of amyloid plaques, can activate brain mononuclear phagocytes (MP; macrophages and microglia), leading to their secretion of neurotoxins. Recent studies strongly suggest that MP-mediated neurotoxicity plays an important role in the pathogenesis of Alzheimer's disease (AD). To further explore this notion, human monocyte-derived macrophages (MDM) were stimulated with naturally secreted α-processing soluble amyloid precursor protein/p3 (αAPPs/p3) or β-processing APP/Aβ (βAPPs/Aβ). MDM conditioned media (MCM) was recovered and tested for its ability to activate recombinant N-methyl-D-aspartate (NMDA) receptor subtype NR1a/NR2B expressed in Xenopus oocytes. Pressure ejection of αAPPs/p3- and βAPPs/Aβ-stimulated MCM produced inward currents of 59.5±8.9 nA (mean±S.E.M., n=31) and 111.1±21.0 nA (n=42) in NR1a/NR2B-expressing oocytes, respectively. The MCM-induced currents were concentration dependent and blocked by 50 μM of the NMDA receptor antagonist 2-amino-5-phosphnovalerate, but not by a non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (20 μM). The αAPPs/p3- and βAPPs/Aβ-stimulated MCM placed in non-injected oocytes failed to generate inward current. These results demonstrate that APPs/Aβ-stimulated MCM directly activate NMDA receptor subtypes relevant in the pathogenesis of AD.",
keywords = "Alzheimer's disease, Amyloid precursor protein, Aβ, Macrophages, NMDA receptors, PC12 cells, Xenopus oocytes",
author = "Huangui Xiong and Laura McCabe and Joseph Costello and Eric Anderson and Gregory Weber and Tsuneya Ikezu",
year = "2004",
month = "8",
day = "1",
doi = "10.1016/j.neurobiolaging.2003.09.007",
language = "English (US)",
volume = "25",
pages = "905--911",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages

T2 - Implications for the pathogenesis of Alzheimer's disease

AU - Xiong, Huangui

AU - McCabe, Laura

AU - Costello, Joseph

AU - Anderson, Eric

AU - Weber, Gregory

AU - Ikezu, Tsuneya

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Amyloid-β peptide (Aβ), the major component of amyloid plaques, can activate brain mononuclear phagocytes (MP; macrophages and microglia), leading to their secretion of neurotoxins. Recent studies strongly suggest that MP-mediated neurotoxicity plays an important role in the pathogenesis of Alzheimer's disease (AD). To further explore this notion, human monocyte-derived macrophages (MDM) were stimulated with naturally secreted α-processing soluble amyloid precursor protein/p3 (αAPPs/p3) or β-processing APP/Aβ (βAPPs/Aβ). MDM conditioned media (MCM) was recovered and tested for its ability to activate recombinant N-methyl-D-aspartate (NMDA) receptor subtype NR1a/NR2B expressed in Xenopus oocytes. Pressure ejection of αAPPs/p3- and βAPPs/Aβ-stimulated MCM produced inward currents of 59.5±8.9 nA (mean±S.E.M., n=31) and 111.1±21.0 nA (n=42) in NR1a/NR2B-expressing oocytes, respectively. The MCM-induced currents were concentration dependent and blocked by 50 μM of the NMDA receptor antagonist 2-amino-5-phosphnovalerate, but not by a non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (20 μM). The αAPPs/p3- and βAPPs/Aβ-stimulated MCM placed in non-injected oocytes failed to generate inward current. These results demonstrate that APPs/Aβ-stimulated MCM directly activate NMDA receptor subtypes relevant in the pathogenesis of AD.

AB - Amyloid-β peptide (Aβ), the major component of amyloid plaques, can activate brain mononuclear phagocytes (MP; macrophages and microglia), leading to their secretion of neurotoxins. Recent studies strongly suggest that MP-mediated neurotoxicity plays an important role in the pathogenesis of Alzheimer's disease (AD). To further explore this notion, human monocyte-derived macrophages (MDM) were stimulated with naturally secreted α-processing soluble amyloid precursor protein/p3 (αAPPs/p3) or β-processing APP/Aβ (βAPPs/Aβ). MDM conditioned media (MCM) was recovered and tested for its ability to activate recombinant N-methyl-D-aspartate (NMDA) receptor subtype NR1a/NR2B expressed in Xenopus oocytes. Pressure ejection of αAPPs/p3- and βAPPs/Aβ-stimulated MCM produced inward currents of 59.5±8.9 nA (mean±S.E.M., n=31) and 111.1±21.0 nA (n=42) in NR1a/NR2B-expressing oocytes, respectively. The MCM-induced currents were concentration dependent and blocked by 50 μM of the NMDA receptor antagonist 2-amino-5-phosphnovalerate, but not by a non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (20 μM). The αAPPs/p3- and βAPPs/Aβ-stimulated MCM placed in non-injected oocytes failed to generate inward current. These results demonstrate that APPs/Aβ-stimulated MCM directly activate NMDA receptor subtypes relevant in the pathogenesis of AD.

KW - Alzheimer's disease

KW - Amyloid precursor protein

KW - Aβ

KW - Macrophages

KW - NMDA receptors

KW - PC12 cells

KW - Xenopus oocytes

UR - http://www.scopus.com/inward/record.url?scp=3042651847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042651847&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2003.09.007

DO - 10.1016/j.neurobiolaging.2003.09.007

M3 - Article

C2 - 15212844

AN - SCOPUS:3042651847

VL - 25

SP - 905

EP - 911

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 7

ER -